the region of interest followed by restriction fragmentation, ligation and cloning in E. coli 10 . The cloned junctions can be precise depending on primer design, and unique restriction sites can be added to the middle of the Target-PO oligos for easy downstream manipulation of in vivo cloned fragments. It can be envisioned that the PO protocol could generate clones of much larger or smaller fragments than the 11.6-to 31.5-kb fragments exemplified in this protocol.
Furthermore, the KO protocol could be extended to include other downstream applications. Insertional mutants may be created with the pheS-gat FRT cassette such that the counterselectable markers could be used to counterselect and generate reporter-gene fusions, in-frame nonpolar deletions and chromosomal point mutations in these β-proteobacteria, B. thailandensis and B. pseudomallei, as previously described for other γ-proteobacteria species 1 . Overall, the ability to perform these types of genetic manipulations in these species using λ-Red recombineering significantly simplifies and reduces experimental labor, allowing high-throughput targeted chromosomal manipulation. For example, our laboratory has used this to KO over 200 targeted and confirmed mutations in 1 month through the efforts of two graduate students.
Limitations of the present protocol
The limitations of the current protocol are that (i) there is a requirement for minimal medium (typically 1× M9 glucose (MG)) supplemented with glyphosate (GS) or chlorinated phenylalanine (cPhe) during gat selection or pheS counterselection; (ii) when introduced into E. coli at high copy number, certain PO gene products may be toxic to the cell, potentially limiting the nature of downstream applications; and (iii) this protocol has been performed successfully in only the naturally transformable strains of B. thailandensis and B. pseudomallei (~50% of the strains tested in this study). We have not been able to extend its use to the nonnaturally transformable Burkholderia strains (e.g., B. pseudomallei strain K96243 and Burkholderia mallei strain ATCC23344) because of potentially inefficient electrotransformation and/or restriction barriers against double-stranded DNA. Various published electroporation methods [11] [12] [13] were tested in non-naturally transformable strains (e.g., B. pseudomallei K96243 and B. mallei ATCC23344), but no colonies or recombinants were obtained. In these non-naturally transformable species and strains, mutation could be created with other established mutagenesis procedures as previously described 8, 9, 12, 14 . However, λ-Red recombineering has a very broad host range (bhr), and we strongly believe that these 17 driven by the arabinose-inducible promoter (P araB ). (b) Plasmid pKaKa2 is maintained in ara − E. coli and B. pseudomallei strains by the B. thailandensis arabinose-utilization operon and growth on arabinose minimal medium, in which λ-Red genes are driven by the rhamnose-inducible promoter. (c) Broadhost-range (bhr) replicating plasmid used for PO recombineering (in vivo cloning). Target-PO1 and Target-PO2 indicate primers (blue arrows) with 40-45 bp homology to the targeted chromosomal region, used to obtain PCR products (oriT-ColE1ori-gat-ori1600-rep) to PO targeted sequences. (d) The pheS-gat and sacB-gat FRT cassettes used for KO recombineering experiments. Target-KO1 and Target-KO2 indicate primers (blue arrows), with 40-45 bp homology to chromosomal regions, used to amplify this cassette in KO experiments. Abbreviations: araC Ec of pKaKa1, activator of the arabinose-inducible promoter (P araB ) from E. coli; araBCDEFGHI of pKaKa2, B. thailandensis arabinose-utilization operon 10 ; bla, encodes β-lactamase; ColE1-ori, ColE1 origin of replication obtained from high-copynumber pUC vectors 22 ; FRT, yeast 2 µm plasmid Flp recombination target; gat, glyphosate (GS) acetyltransferase for GS resistance 9 ; Km r , kanamycin resistance, encoded by nptII 23 ; lacZα, encodes LacZ α peptide; mob-oriT, RP4-dependent conjugal origin of transfer of B. bronchiseptica cryptic plasmid pBBR1 (ref. 16) ; ori 1600 -rep, Pseudomonas and Burkholderia bhr origin of replication 24 ; ori-rep, bhr replicon of B. bronchiseptica pBBR1 plasmid 16 ; oriT, plasmid RP4 origin of transfer for conjugation; P araB , arabinose-inducible promoter 3 ; P lac , E. coli lactose operon promoter; P rhaBAD , rhamnose-inducible promoter 25 ; P S12 and PC S12 , constitutive promoters of B. pseudomallei and B. cenocepacia rpsL genes 26 ; pheS, engineered gene encoding a mutant version of the α-subunit of phenylalanyl tRNA synthase 8 ; rhaR and rhaS, regulators of the rhamnose-inducible promoter 25 ; sacB, encoding for a modified levansucrase counterselectable marker 14 . 8, 9 , along with the arabinose-utilization operon (araBCDEFGHI) 10 and the more established sacB counterselectable marker 14 . Two new bhr replicating plasmids containing λ-Red genes (gam, bet and exo) that are inducible with arabinose and rhamnose, pKaKa1 and pKaKa2, respectively, were engineered for this protocol (Fig. 1a,b) . pKaKa1 is typically used for B. thailandensis, using the kanamycin-resistance selectable marker and the pheS gene as a counterselectable marker in the presence of cPhe, as described previously 8 . As kanamycin resistance has limited use in wild-type B. pseudomallei strains 15 , the alternative B. thailandensis arabinose-utilization operon (araBCDEFGHI) 10 was used as a metabolic marker for selection of pKaKa2 in B. pseudomallei, whereas the sacB gene was chosen for counterselection, using sucrose. The pKaKa1 and pKaKa2 plasmids contain the Bordetella bronchiseptica bhr origin for replication in Gramnegative bacteria 16 . These plasmids can be electrotransformed into B. thailandensis and B. pseudomallei or conjugated from RP4-harboring E. coli (e.g., E1299, Table 1 ), in which they can eventually be cured using cPhe or sucrose after recombineering. The λ-Red proteins Gam, Redβ and Redα (encoded by gam, bet and exo) are In vivo PO strategy. The in vivo cloning or PO protocol involves the amplification of a PCR product from the engineered plasmid pAM3G, containing a GS-resistance selectable marker 9 , a bhr origin of replication and an origin of transfer for conjugation (Figs. 1c and 2) . The PCR-amplified fragment (~2.8 kb), flanked by sequences homologous to the chromosomal PO region, is incubated with cells expressing the λ-Red proteins. As examples of the PO protocol, we will individually describe the in vivo cloning of the B. thailandensis arabinose-utilization operon (araABCDEFGHI, 11.6 kb) 10 and the B. pseudomallei siderophore malleobactin biosynthetic cluster (mba-cluster, 31.5 kb) 18 into the Underlined are homologous sequences to targets on the chromosome. Boldface sequences in the long oligos are identical to the shorter oligos used in the second PCR (Step 5 of the protocol). In italics are reverse complementary sequences of mbaF-KO1 and mbaS-KO5, where these primers are used to generate ~100 bp PCR product to create the unmarked mutation (Step 13A).
pAM3G replicating plasmid backbone. The PO strategy for the mba cluster is depicted in Figure 2 . Positive PO frequencies of GS-resistant colonies with araABCDEFGHI clones ranged from 88 to 93% in B. thailandensis ( Table 3) , whereas cloning frequencies for the mba cluster ranged from 90 to 100% in B. pseudomallei ( Table 4) .
Overview of KO strategy. The KO procedure uses a PCR-amplified pheS-gat FRT cassette flanked by 40-45 bp of sequence homologous to the targeted chromosomal regions (Fig. 1d) . Upon introduction of the pKaKa2 plasmid and induction of the expression of λ-Red proteins, KOs can be achieved in one step by transformation of the PCR-amplified pheS-gat cassette and selection on GS. The helper plasmid pKaKa2 could be cured by counterselection with sacB on sucrose-containing medium (Fig. 1b) . Figure 3 depicts an example of chromosomal KO using pKaKa2 in B. pseudomallei at high frequencies (88-92%, Table 4 ). We foresee that for those laboratories approved to use kanamycin-resistance selection in B. pseudomallei, pKaKa1, in conjunction with the sacB-gat cassette, could be used to generate KO in B. pseudomallei (Fig. 1a,d ). In this case, pKaKa1 could be cured by counterselection with pheS on cPhe-containing medium.
Recycling of useful markers. There are very few selectable or counterselectable markers for genetic manipulation in most bacteria, and the ability to reuse these precious markers in the same strain is essential. This protocol describes two strategies for recycling the pheS-gat or sacB-gat FRT cassettes (Fig. 3) . A second round of λ-Red protein induction followed by incubation of cells with a short PCR fragment flanked by 40-45 bp homologous to the targeted region on the chromosome (Fig. 3) will generate an unmarked KO mutant in B. thailandensis or B. pseudomallei. This strategy can be achieved quickly because of the presence of pKaKa1 or pKaKa2 from the previous KO procedure. In an alternative strategy that does not require λ-Red proteins, the unmarked KO mutants can be generated by incubating cells with a PCR fragment containing flp (Fig. 3) .
Overview of the protocol. This PO/KO protocol is summarized in Figure 4 . Step 13B). When desired, the helper plasmid can be cured by pheS/sacB counterselection (Step 14). The step-by-step protocol is described below. a Each experiment was performed in triplicate, and average number of GS-resistant colonies is shown with standard error of the mean. On average, 12 GS-resistant colonies were PCR screened for positive pullout and the percentage is shown in parentheses. b The first PCR product, amplified with the non-PAGE purified long oligos, was directly used for PO. c The second PCR product, amplified using shorter non-PAGE purified oligos and the first PCR product as template, was used for PO. Step 8A/B
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MaterIals

REAGENTS
Amino acids: 2,6-diaminopimelic acid (DAP; 100 mg ml − 1 in 1 M NaOH, Acros Organics, cat. no. 235540010); l-leucine (Leu; 1 M; filter sterilized, Acros Organics, cat. no. 125121000); l-lysine (Lys; 1 M; filter sterilized, Acros Organics, cat. no. 303340050), l-methionine (Met; 1 M; filter sterilized, Acros Organics, cat. no. 166160250), l-threonine (Thr; 1 M; filter sterilized, Acros Organics, cat. no. 138930050) and (S)-tryptophan (Trp; 1 M; filter sterilized, Acros Organics, cat. no. 140591000) Bacterial strains Burkholderia strains ( Table 1) Burkholderia thailandensis E264 (available from BEI Resources) Burkholderia pseudomallei 1026b, Bp0085, Bp0091, Bp0094, Bp4001, Bp4003, Bp4122, Bp4141, Bp4144 and Bp6340 ! cautIon Acquisition, possession and manipulation of B. pseudomallei strains in the United States are limited to FBI-screened and -cleared personnel, and experiments must be performed in CDC-and US Department of Agriculture (USDA)-approved and registered BSL-3 select agent facilities. E. coli strains ( Table 1 ; available from T.T.H.) Plasmids ( Table 1 ; available from T.T.H.) pKaKa1 or pKaKa2, replicating plasmids containing inducible λ-Red genes ( Fig. 1) pAM3G, bhr plasmid encoding gat (GS acetyltransferase), source of PCR fragment for PO recombineering pwFRT-PC S12 -pheS-gat or pwFRT-PC S12 -sacB-gat plasmid DNA used as template for KO recombineering pCD13SK-Flp-oriT-asd Ec plasmid DNA used as a template to amplify flp gene-containing fragment Oligonucleotides (see Table 2 ; Integrated DNA Technologies) Target-PO1 (5′-N 40 -GATTCCTTAAGGTATACTTT-3′); N 40 refers to 40 bases of sequence homologous to your target gene. Underlined bases can be common to the target and also anneal to the PCR template to increase efficiency and reduce costs. Target-PO2 (5′-N 40 -ACGGCCTCTAGGCCAGATCC-3′) Target-PO3 (N [16] [17] [18] [19] [20] identical to the 5′-end of Target-PO1) Target-PO4 (N [16] [17] [18] [19] [20] identical to the 5′-end of Target-PO2) Target-rev (N [16] [17] [18] [19] [20] anneals inside of the PO region; use with oligo ori1600-rep-internal to confirm PO by PCR) ori1600-rep-internal (5′-GGAAGATTTCAGATGCTGAG-3′; use with oligo Target-rev to confirm PO by PCR) Target-KO1 (5′-N 40 -CAAGGCGATTAAGTTGGGTA-3′) Target-KO2 (5′-N 40 -GCTCGTATGTTGTGTGGAATTGTGA-3′) Target-KO3 (N [16] [17] [18] [19] [20] identical to the 5′-end of Target-KO1) Target-KO4 (N [16] [17] [18] [19] [20] identical to the 5′-end of Target-KO2) Target-KO5 (5′-N 40 -TACCCAACTTAATCGCCTTG-3′; this oligo has identical N 40 as Target-KO2) Target-up-out (N [16] [17] [18] [19] [20] anneals outside of the homologous region; use with Target-down-out to confirm KO by PCR) Target-down-out (N [16] [17] [18] [19] [20] anneals outside of the homologous region; use with Target-up-out to confirm KO by PCR) Plac-up (5′-GCCCAATACGCAAACCGCCTCTC-3′) Flp-down (5′-TAAATGGATCCTTATATGCGTCTATTTATG-3′) DNA ladder (100 bp; range 100-1,500 bp, New England Biolabs, cat. no. N3231L) DNA ladder (1 kb; range 0. REAGENT SETUP Agarose gels Agarose gels are prepared by adding molecular-grade agarose to 100 ml of 1× TAE buffer 19 to obtain desired concentrations. The mixture is then heated and allowed to cool in a gel mold. The agarose gels are prepared freshly before use. (Table 1) , Met, Lys and Thr are added at a final concentration of 1 mM, and DAP was added at 200 µg ml − 1 . Sucrose is added at a concentration of 15% (wt/vol). cPhe is added at a concentration of 0.1% (wt/vol), as previously described 8 .
proceDure preparing po/Ko Dna fragment • tIMInG 1 d 1| Design oligonucleotide primers such that the last 45 bases on the 5′ end are homologous to two corresponding regions on the chromosome for the PO/KO method, and order oligos prior to initiating the protocol. When designing the pair of PO or KO oligos, avoid having five consecutive matching base pairs between them within their 5′ ends to prevent intrafragment recombination 2 . All oligos do not require PAGE purification; however, the majority of the long oligos (60-65 bp) produced will be truncated or will have incorrect 5′ ends as the coupling or synthesis efficiency is not 100% (coupling efficiencies are available from oligo manufacturer), resulting in reduced recombineering efficiency (e.g., ~29% of the 60-bp oligos have truncated or incorrect ends when the coupling efficiency is 99%, or up to 95% will have truncated or incorrect ends if coupling efficiency is as low as 95%). To remedy this problem and increase recombineering efficiency at reduced cost, a two-step PCR approach is described below. The first PCR product is obtained using the long oligos, which is used as the template for subsequent amplification by shorter oligos (16-20 bp) annealing to the 5′ ends of the first PCR product. The shorter oligos required for the second PCR should have sequences identical to the 5′ end of the long oligos from the first PCR, which will thus repair them and yield more accurate 5′ ends ( Fig. 1 and table 2 ).
2| Set up one PCR reaction using the long oligos and the following components in a thin-walled PCR tube.  crItIcal step It is essential to use Pfu polymerase or other polymerases that generate blunt ends in order to avoid the addition of unwanted bases (e.g., A at the 3′ end with Taq). The proofreading capability of Pfu polymerase will also significantly increase the fidelity of the PCR products.
3|
Carry out the PCR as described below. Set the lid temperature to 98 °C to prevent condensation of the sample during the reaction. 4| Visualize all PCR reactions by agarose gel electrophoresis using a 1.0% agarose gel submerged in TAE buffer (see REAGENT SETUP). Run alongside DNA ladder (e.g., 1 kb DNA ladder) for estimating PCR product size. If oligos are designed as recommended, PCR products of ~2.7 kb (oriT-ColE1ori-gat-ori1600-rep from pAM3G template) or ~1.8 or 2.3 kb (pheS/sacB-gat from pwFRT-pheS/sacB-gat template) can be expected. Purify DNA from the gel with desired kit or protocol and quantify using a spectrophotometer at 260 nm. This first PCR product could be used directly for recombineering in B. thailandensis, with lower frequencies compared with the second PCR product (table 3) ; however, the first PCR product should not be used directly for B. pseudomallei because of the lower frequencies obtained (table 4) .  pause poInt If not used for transformation immediately, the DNA can be stored at 4 °C for a short period of time.
For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer.
5|
Set up the second PCR using the product from Step 4 as template. Typically, set up four PCR reactions to obtain sufficient amounts of DNA, using the shorter oligos as below. Multiply all of the following components by four and combine in a master mix. Pipette 50 µl of the master mix into four thin-walled PCR tubes.  pause poInt PCR samples can be retained in the PCR machine or stored at 4 °C for a short period of time. For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer.
7| Visualize all PCR reactions by agarose gel electrophoresis, using a 1.0% agarose gel submerged in TAE buffer (see REAGENT SETUP). Run alongside DNA ladder (e.g., 1-kb DNA ladder) to estimate PCR product size. If oligonucleotides are designed as recommended, PCR products of ~2.7 kb (oriT-ColE1ori-gat-ori1600-rep fragment) or ~1.8 or 2.3 kb (pheS/sacB-gat FRT cassette) can be expected. Purify DNA from all bands produced with desired kit or protocol and quantify using a spectrophotometer at 260 nm. Alternative strategy: If cost is not an issue, PAGE-purified long oligos could be ordered and the first PCR product could be used directly for recombineering without the need for a second PCR. The PCR with PAGE-purified long oligos should be set up exactly as the first PCR.  pause poInt If not used for transformation immediately, the DNA can be stored at 4 °C for a short period of time. For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer. ? trouBlesHootInG Introduction of pKaKa1 or pKaKa2 into Burkholderia species 8| The plasmids encoding λ-Red proteins are pKaKa1 (for B. pseudomallei and B. thailandensis) and pKaKa2 (for B. pseudomallei). One of these plasmids should be introduced into bacteria prior to PO/KO experiments, by electroporation or conjugation. Option A describes delivery of pKaKa1 by electroporation. pKaKa1 contains the kanamycin-resistance marker and selection is performed on LB + 500 µg ml -1 Km for B. thailandensis or on LB + 1,000 µg ml -1 Km for B. pseudomallei 21 . Delivery of pKaKa2 by electroporation or conjugation is described in options B and C, respectively. pKaKa2 confers arabinoseutilization ability to B. pseudomallei and is selected for on MA medium. The conjugation method (option C) is particularly useful for delivering plasmid into the select agent B. pseudomallei, as it reduces the risk of generating aerosols during electroporation. Although we only describe the mating protocol for pKaKa2 into B. pseudomallei, conjugation of pKaKa1 into B. pseudomallei could be done similarly. For KO in B. pseudomallei, the pKaKa1 helper plasmid should be used in conjunction with the sacB-gat fragment, whereas pKaKa2 should be used with pheS-gat fragment. (This is the end of day 1.) (ii) After the culture has reached a sufficient density (OD 600 0.8-1.5), spin down all 5 ml in a microcentrifuge at 10,000g for 1 min. Wash the cell pellet with 1 ml of cold, sterile ddH 2 O. Repeat this four more times, adhering to the same centrifugation conditions. ! cautIon Pipette and wash gently to minimize aerosolization of B. pseudomallei culture. Filtered pipette tips should be used for B. pseudomallei to avoid contamination of the pipette. Instead of using cold ddH 2 O, 300 mM sucrose maintained at room temperature may be substituted when washing cells as previously described 15 . Comparable electroporation efficiencies can be obtained by using either method. ? trouBlesHootInG (iv) Immediately add 1 ml of rich broth medium (e.g., LB broth) to the cuvette and transfer to a round-bottom culture tube. Incubate the culture for 1 h at 37 °C with shaking at 225 r.p.m. in order to allow for kanamycin-resistance gene expression (Fig. 1a) . (v) Pipette 100 µl of the recovery mixture onto an LB + 500 µg ml -1 Km (B. thailandensis) or LB + 1,000 µg ml -1 Km (B. pseudomallei) plate while centrifuging the rest of the recovered culture at 16,000g for 1 min prior to plating. Remove all but 100 µl of medium, then spread the remaining culture on another LB + Km plate. Incubate both plates in a 37 °C incubator until colonies appear, ~2 d later.
(B) electroporation of pKaKa2 into B. pseudomallei • tIMInG 4 d
(i) In a 15-ml Falcon tube, grow B. pseudomallei in 5 ml of LB broth overnight at 37 °C in a shaking incubator set to 225 r.p.m. (This is the end of day 1.) (ii) After the culture has reached a sufficient density (OD 600 0.8-1.5), spin down all 5 ml in a minicentrifuge at 10,000g for 1 min. Wash the cell pellet with 1 ml of cold, sterile ddH 2 O. Repeat this four more times adhering to the same centrifuge conditions. Alternatively, instead of using cold ddH 2 O, 300 mM sucrose maintained at room temperature may be substituted when washing cells as previously described 15 . Comparable electroporation efficiencies can be obtained using either method. (iii) Remove all water from the washed pellet and resuspend the cell pellet with 40 µl of cold, sterile ddH 2 O. Add 1 µl of purified pKaKa2 plasmid (~0.2 µg) DNA to the competent cells and transfer the mixture to an electroporation cuvette. Place the eletroporation cuvette into the electroporator shock chamber and apply a shock of 2.5 kV, 25 µF and 200 Ω.
Ensure an exponential decay of the applied shock and the absence of an arc. ? trouBlesHootInG (iv) Immediately add 1 ml of rich broth medium (e.g., LB broth) to the cuvette and transfer to a 15-ml culture tube with a screw cap. Incubate the culture for 1 h at 37 °C with shaking at 225 r.p.m. for recovery. (v) Transfer the recovery mixture into a 1.5-ml microcentrifuge tube and spin in a minicentrifuge at 10,000g for 1 min.
Discard the supernatant, wash the cell pellet twice with 1 ml of 1× M9 buffer and resuspend the cell pellet in the same volume of 1× M9 buffer. Plate 100 µl of the resuspended cells onto an MA agar plate, while centrifuging the rest at 16,000g for 1 min. Remove all but 100 µl of buffer, then spread the remaining culture on another MA agar plate. Incubate both plates in a 37 °C incubator until colonies appear, ~2 d later.
(c) conjugation of pKaKa2 into B. pseudomallei • tIMInG 3 d
(i) Grow a single colony of B. pseudomallei in 2 ml of LB broth, and grow the E. coli donor harboring pKaKa2 (E1354/ pKaKa2) in 2 ml of MA, 1 mM Leu, 1 mM Lys, 1 mM Met, 1 mM Thr, 1 mM Trp and 100 µg ml − 1 DAP, overnight at 37 °C in a shaking incubator set to 225 r.p.m. (This is the end of day 1.) (ii) After both cultures have reached a sufficient density (OD 600 0.8-1.5), spin down 1 ml of each culture separately in a minicentrifuge at 10,000g for 1 min. Remove all medium from the E. coli donor and all but 40 µl LB from the B. pseudomallei tube, and resuspend both pellets in this 40 µl of LB. Spot this 40-µl mixture on the surface of a dried and prewarmed (37 °C) LB agar plate, and incubate at 37 °C for 4 h. (iii) Gently scrape the cells off the plate with sterile inoculation loop and resuspend in 1 ml of 1× M9 in a 1.5-ml microcentrifuge tube; spin in a minicentrifuge at 10,000g for 1 min. Discard the supernatant, wash the cell pellet once more with 1 ml of 1× M9 buffer and resuspend the cell pellet in the same volume of 1× M9 buffer. Plate 100 µl of the resuspended cells onto an MA agar plate and incubate in a 37 °C incubator until colonies appear, ~2 d later. 
Induction of l-red
pseudomallei).
To verify a positive PO, a Target-rev gene-specific oligonucleotide (e.g., araI-rev or mbaS-rev) and a pAM3G-specific oligonucleotide (e.g., ori1600-rep-internal) should be used for PCR verification ( 8 . Alternatively, instead of purifying plasmids from liquid culture, pipette 100 µl of the culture into a 1.5-ml microcentrifuge tube and boil the tube for 8 min. Centrifuge the tube at 16,000g for 1 min to spin down the cell debris. Electroporate 5 µl of the boiled supernatant into an electrocompetent E. coli cloning strain (e.g., EPMax-10B or E1889 in table 1) for further downstream applications. ? trouBlesHootInG (B) Ko screen in B. pseudomallei • tIMInG ~5 h (i) Single colonies, with the pheS/sacB-gat fragment recombined into the chromosome deleting the target gene, should appear with a similar frequency as shown in tables 4 and 5 (typically, when 0.5-2 µg KO DNA is used, 20-50 colonies should be expected). To verify a successful KO, a set of Target-up-out and Target-down-out oligos annealing to chromosomal regions outside the targeted KO primers are used (e.g., mbaF-out and mbaS-out, table 2). PCR verification should be set up exactly as described above in Steps 2 and 3 with extension time ~1 min kb − 1 . ? trouBlesHootInG (ii) After verification of the KO, it is critical to purify the positive colonies once before growth for storage. To purify, transfer positive colonies onto an MG + GS plate and streak out for single colonies. (a) As an example, the arabinose-utilization operon was pulled out from the B. thailandensis chromosome using the pAM3G backbone with 45-bp homologous sequences to the araA and araI genes. The genetic map of the resulting plasmid is shown with the oligos in blue used for PCR screening. Using these oligos, ten independent POs were screened by PCR. As indicated by the arrow, a PCR product with the correct size was obtained in 89% (eight out of nine) of the GS-resistant colonies. Abbreviations: NC, negative control using wild-type B. thailandensis as template; L, 1-kb DNA ladder from New England Biolabs. (b) Similarly, the mba cluster was pulled out from the B. pseudomallei strain 1026b chromosome, and the genetic map of the resulting plasmid, pAM3G-mba, was shown with the oligos in blue used for PCR screening. Using these oligos, 10 independent POs were screened by PCR. As indicated by the arrow, PCR products with the correct size were obtained in 90% (nine out of ten) of the GS-resistant colonies. by λ-Red recombination, generating a markerless mutant. Option B describes Flp-mediated excision of the pheS-gat or sacBgat fragment, generating an unmarked mutant with a single FRT scar remaining in the target gene.
(a) replacement of the pheS-gat or sacB-gat cassette with overlapping oligos (i) Typically, set up two PCR reactions to obtain sufficient amounts of DNA, using the overlapping primers. Multiply all of the following components by two and combine in a master mix. Pipette 50 µl of the master mix into two thin-walled PCR tubes.  crItIcal step It is essential to use Pfu polymerase or other polymerases that generate blunt ends in order to avoid the addition of unwanted bases. The proofreading capability of Pfu polymerase will significantly increase the fidelity of the PCR products. (ii) Carry out the PCR as described below. Set the lid temperature to 98 °C to prevent condensation of the sample during the reaction.  pause poInt At this time, the DNA can be stored at 4 °C for a short period of time. For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer. (iii) Visualize PCR reactions by agarose gel electrophoresis, using a 2.0% agarose gel submerged in TAE buffer (see REAGENT SETUP). Run alongside DNA ladder (e.g., 100-bp DNA ladder) to estimate PCR product size. A single PCR product of ~100 bp should be observed. Recover and purify DNA from the gel with desired kit or protocol and quantitate using a spectrophotometer.  pause poInt The DNA can be stored at 4 °C for a short period of time. For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer. (iv) Inoculate the purified colony obtained in Step 12B(ii) into 4 ml of MA broth (B. pseudomallei with pKaKa2 and the pheS-gat cassette) or 4 ml of LB + 1000 µg ml -1 Km broth (B. pseudomallei with pKaKa1 and the sacB-gat cassette) and incubate at 37 °C with shaking at 225 r.p.m. When the culture grows to an OD 600 of ~0.8, add rhamnose to a final concentration of 0.2% (B. pseudomallei with pKaKa2 and the pheS-gat cassette) or arabinose to a final concentration of 10 mM (B. pseudomallei with pKaKa1 and the sacB-gat cassette) in order to induce the λ-Red system. After 4 h of induction, harvest all 4 ml of culture by centrifuging at 16,000g for 1 min. Discard the supernatant and resuspend the cell pellet in 20 µl of LB. Incubate the resuspended cells with DNA obtained in
Step 13A(iii) below immediately.  crItIcal step Induction at the proper OD is crucial for efficient recombineering. If the OD is too low, toxicity of λ-Red proteins can cause the cells to stop growing. If the OD is too high, cells tend to be 'unhealthy' after induction and recombineering efficiencies decrease.  pause poInt At this time, the DNA can be stored at 4 °C for a short period of time. For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer. (iii) Visualize PCR reactions by agarose gel electrophoresis, using a 1.0% agarose gel submerged in TAE buffer (see REAGENT SETUP). Run alongside DNA ladder (e.g., 1-kb DNA ladder) to estimate PCR product size. A single PCR product of ~2.6 kb should be observed. Recover and purify DNA from the gel with desired kit or protocol and quantitate using a spectrophotometer.  pause poInt The DNA can be stored at 4 °C for a short period of time. For extended storage, it is recommended that the reaction be placed in a − 20 °C freezer. • tIMInG Steps 1-7, Preparing KO/PO DNA: 1 d
Step 8, Introduction of pKaKa1 or pKaKa2: 3-4 d
Step 9, Induction: 18 h Steps 10 and 11, DNA incubation: 4 d
Step 12, PCR screening: 1-3 d
Step 13, Recycling of markers: 3 d
Step 14, Curing of pKaKa1 or pKaKa2: 5 d
antIcIpateD results po recombineering efficiency of chromosomal fragments from B. thailandensis Using the protocol provided will typically produce 40-200 colonies depending on the amount of DNA and type of PCR product used (table 3) . As an example, the B. thailandensis ara operon was pulled out of the chromosome with a PCR fragment containing a bhr origin of replication. Successful removal of the ara operon was verified using an ara-specific primer and a plasmid-origin-specific primer (Fig. 5a) . A high percentage (~90%) of the colonies contained the pulled-out fragment (table 3 and Fig. 5a ). Such a percentage should be common as these numbers were obtained from experiments that were done in triplicate, and bacteria that do not contain gat should not grow on medium containing GS.
po recombineering in B. pseudomallei Using the helper plasmid pKaKa2 (constructed with the ara operon pulled out from B. thailandensis), the efficiencies of PO recombineering in B. pseudomallei are shown in table 4; these are relatively lower than those of PO in B. thailandensis (table 3) . Introduction of pKaKa2 into B. pseudomallei can be achieved through electroporation or conjugation. High efficiency can be expected from both methods. Selection and maintenance of pKaKa2 in B. pseudomallei is simple and tight, as cells without the plasmid will not be able to metabolize arabinose as a nutrient source. A higher concentration of GS (0.3% instead of 0.04% for B. thailandensis) should be used for selection of the PO plasmid. Successful PO of chromosomal fragments should be confirmed by PCR using two oligos, of which one anneals to the plasmid backbone and the other to the PO fragment (e.g., mba cluster in Fig. 5b ). High frequencies (90-100%) of successful PO can be expected ( Fig. 5b and table 4) . No GS-resistant colonies were observed when the λ-Red system was not induced, indicating that recA-mediated recombination did not recombine 40-45 bp of homology at any detectable frequencies ( Use a fragment containing a low-copy-number origin for PO (e.g., pBBR-based origin) obtained when 0.5-2 µg KO DNA fragment is used. Independent GS-resistant isolates were screened by phenotypic and PCR confirmation (Fig. 6a,b) , showing 100% frequency of successful KO. Generally, high frequencies (90-100%) are expected for the successful KO of chromosomal fragments when the gat marker is used for selection (Fig. 6a,b) . Two options, via a second λ-Red-mediated recombination or Flp-catalyzed excision, were provided for the removal of the pheS-gat or sacB-gat FRT cassette from the mutant chromosomes. The λ-Red-mediated recombination results in a clean deletion of the chromosome fragment, whereas the Flp-catalyzed (λ-Red independent) excision leaves a single 'FRT-scar' inside the targeted fragment. Alternatively, instead of flp-containing PCR product incubation, we have expressed Flp transiently by conjugating the suicidal vector, pCD13SK-Flp-oriT-asd Ec , from E. coli ∆asd strain (E1354 in table 1) and immediately counterselected the conjugation mix on cPhe-or sucrose-containing medium, yielding GS-sensitive clones. Use of the pheS-gat or sacB-gat FRT cassette for KO makes the creation of unmarked mutations easy, as little to no resistance to cPhe or sucrose was observed. As an example, the removal of the pheS-gat cassette was close to 100% efficient (Fig. 6c,d with the mba cluster as an example). The confirmation of unmarked mutations is simple, as the PCR products amplified using outside primers are small (approximately 200-500 bp; Fig. 6c,d ). After introduction of the pKaKa2 plasmid, unmarked mutant could be obtained in ~10 d. pKaKa2 could be easily cured or maintained for the subsequent manipulation, such as creating multiple mutations in the same strain or introducing reporter-gene fusions. If required, the curing of pKaKa2 on sucrose medium could be confirmed by the inability to grow on arabinose as a sole carbon source. The curing efficiency was observed to be close to 100% (Fig. 6) . If pKaKa1 in conjunction with the sacB-gat fragment was used for B. pseudomallei KO, then the efficiencies for KO and curing of helper plasmid pKaKa1 are expected to be similar to those when pKaKa2 and pheS-gat are used. Since the first submission of this protocol, we have used this system to PO and KO genes in both species with relative ease.
To demonstrate and extend the use of λ-Red recombineering in other naturally transformable B. pseudomallei strains, we tested 20 additional B. pseudomallei strains and found that 9 were naturally transformable (table 1). We chose these nine strains encompassing clinical and environmental isolates (table 1). The pheS-gat cassette was used to successfully KO the asd gene in these nine B. pseudomallei strains, and results are shown in table 5 and Figure 7 . The frequencies Figure 6 | Phenotypic and PCR confirmation for the mba-cluster knockouts in the B. pseudomallei. As an example, the B. pseudomallei strain 1026b mba cluster was knocked out, using the pheS-gat fragment with 45-bp homologous sequences to the mbaF and mbaS genes. A total of 25 independent knockout mutants were spotted onto a CAS (chrome azurol S) plate 27 , along with the wild-type 1026b strain ( + ) and the enterobactinnegative E. coli mutant ( − , JW0586-1 (ref. 28)) as the positive and negative control, respectively. As the mba cluster is involved in malleobactin synthesis and secretion, knockout mutants display the malleobactin-negative phenotype as an absence of orange halo. The knockout frequency is 100% in these 25 isolates. (b) Oligos annealing outside the homologous region were used to screen ten isolates from a for successful KOs (oligos mbaF-out and mbaS-out as in Fig. 3) . A total of 100% (ten out of ten) of the GS-resistant colonies were shown to have the pheS-gat fragment inserted into the mba cluster, as indicated by the arrow. NC indicates negative control using wildtype 1026b as the PCR template. L indicates the 1-kb DNA ladder from New England Biolabs. (c,d) Following the second λ-Red-mediated recombination with overlapping oligos (c) or Flp-mediated excision (d), unmarked mutations were generated. PCR confirmation was done for both methods, using the same outside oligos as in b, yielding smaller PCR products lacking pheS-gat as indicated by arrows in c and d. In both c and d, L indicates the 100-bp DNA ladder from New England Biolabs. (e) After mutant construction, the pKaKa2 helper plasmid was cured from the 1026b-∆mbapheS-gat by sacB counterselection on sucrose-containing medium. Total nucleic acids were purified from strain 1026b-∆mbapheS-gat/pKaKa2 (lane 1) and four isolates of cured strain 1026b-∆mbapheS-gat without pKaKa2 (lanes 2-5) for Southern hybridization analysis, using the entire pKaKa2 plasmid as a probe. As indicated by arrow, the helper plasmid pKaKa2 exists only in strain 1026b-∆mbapheS-gat/pKaKa2, whereas the entire pKaKa2 sequence is completely lost in 1026b-∆mbapheS-gat after curing. L, prebiotinylated DNA ladder from New England Biolabs (mixture of HindIII-digested λ DNA and HaeIII-digested φ×174 DNA). (f) To demonstrate the integrity of the PO fragment, boiling preps of two 1026b/pAM3G-mba isolates were electroporated directly into 1026b-mbaFRT mutant for the complementation study (B1 and B2). In addition, the same boiling preps of 1026b/pAM3G-mba were transformed into an E. coli restriction-minus strain; plasmids were then reisolated from E. coli and reintroduced to complement the 1026b-mbaFRT mutant (E1 and E2). These four complemented strains were spotted on a CAS plate along with positive ( + , wild-type 1026b) and negative ( − , 1026b-mbaFRT) controls, and all four isolates regained the ability to produce malleobactin. (g) Boiling preps from five different isolates of 1026b/pAM3G-mba were electroporated into E. coli JW0586-1 strain, and the resulted strains were spotted onto CAS plates with positive ( + , E. coli K-12 strain) and negative ( − , E. coli JW0586-1 strain) controls. As shown, the B. pseudomallei 1026b mba operon complemented the enterobactin-deficient phenotype of E. coli JW0586-1 strain. 
